Tiracizine
- Level
- Commodity
- Parent
- 51292900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292914This classification denotes an antiarrhythmic agent with the molecular formula C21H25N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9UUO2T61K7, chemically known as ethyl 5-(n,n-dimethylglycyl)-10,11-dihydro-5h-dibenz(b,f)azepine-3-carbamate but generally known as tiracizine, which bears US NIH Compound Identifier 71264. European Medicines Agency schedules Tiracizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11114MIG. The term TIRACIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules tiracizine in its Anatomical Therapeutic Chemical (ATC) Classification. TIRACIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiracizine under HS 29339930 and SITC 51577. As of Q4 2014, TIRACIZINE remains the US FDA Preferred Term for this commodity. Tiracizine bears US NLM identifiers UMLS ID C0145975 and NCI Concept Code C75137. SMILES: O=C(N1c2c(CCc3c1cccc3)ccc(NC(=O)OCC)c2)CN(C)C.
Same parent
Under 51292900 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.